Hexagon Nutrition Limited (NSE:HEXAGON)
68.38
-2.62 (-3.69%)
At close: Jul 7, 2026
Hexagon Nutrition Revenue
In the fiscal year ending March 31, 2026, Hexagon Nutrition had annual revenue of 3.83B INR with 17.76% growth. Hexagon Nutrition had revenue of 1.15B in the quarter ending March 31, 2026, with 84.19% growth.
Revenue
3.83B
Revenue Growth
+17.76%
P/S Ratio
2.20
Revenue / Employee
8.50M
Employees
450
Market Cap
8.41B
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 3.83B | 576.99M | 17.76% |
| Mar 31, 2025 | 3.25B | 271.98M | 9.14% |
| Mar 31, 2024 | 2.98B | 192.30M | 6.90% |
| Mar 31, 2023 | 2.79B | 76.29M | 2.82% |
| Mar 31, 2022 | 2.71B | 593.81M | 28.08% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| TTK Healthcare | 8.57B |
| Anuh Pharma | 7.72B |
| Sudarshan Pharma Industries | 7.03B |
| Kopran | 6.81B |
| Lincoln Pharmaceuticals | 6.71B |
| Wanbury | 6.50B |
| Fermenta Biotech | 5.25B |
| ZIM Laboratories | 3.74B |